DIABETIC RETINAL NEURODEGENERATION : A CASE STUDY
Keywords:
people, complication, complicationsAbstract
According to the International Diabetes Federation, there are 537 million people with diabetes in the world [1]. Patients with diabetes mellitus (DM) are at a significantly higher risk of developing complications of the underlying disease, including diabetic retinopathy (DR). Diabetic retinopathy is not only the most common complication of diabetes but it is also recognized as the most severe, as it often leads to irreversible vision loss. In 2021, there were 103 million people worldwide with some form of diabetic retinopathy, accounting for 22.3% of the total number of diabetic patients
References
International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation, 2021.
Ruchkin M. P. i Dr. Neurodegeneration setchatki u patient s sakharnym diabetes 2 tipa //Tikhookeansky meditsinsky journal. - 2020. - No. 3 (81).- S. 62-64.
Shawky SS, Elagouz MH, Ismail AM, Elhawary AM. Macular thickness in healthy controls and diabetics without diabetic macular edema. Egypt Retina J. 2018;5:1–5.
Filippov V. M. i Dr. The role of biomarkers in neurodegeneration in diabetic retinopathy //Vestnik ophthalmology. - 2021. - T. 137. - no. 5-2. - S. 314-322.
Simo R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetology. 2018;61(9):1902–12.
Sohn EH et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus //Proceedings of the National Academy of Sciences. - 2016. - T. 113. - no. 19. – S. E2655-E2664.
Catalani E., Cervia D. Diabetic retinopathy: A matter of retinal ganglion cell homeostasis //Neural
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
